Insulin Family intermediate
Insulin Therapy and Weight Gain
Mechanisms and clinical management of weight gain associated with insulin therapy.
By Encyclopeptide Editorial | 1 min read
insulin weight-gain adiposity metabolic diabetes
Overview
Weight gain is a common side effect of insulin therapy, typically 2-6 kg in the first year. The mechanism involves restoration of anabolic insulin signaling, reduced glycosuria, and appetite stimulation.
Comparative Weight Gain
| Insulin Type | Average Weight Gain |
|---|---|
| NPH | 3-5 kg/year |
| Glargine U100 | 2-4 kg/year |
| Degludec | 1.5-3 kg/year |
| Glargine U300 | 1-3 kg/year |
Mitigation Strategies
- Use of GLP-1 receptor agonists in combination
- Dose optimization to minimize excess
- Patient education on diet and exercise
- Consideration of SGLT2 inhibitor co-therapy
Chemical Identity
| Property | Value |
|---|---|
| Name | Insulin Therapy and Weight Gain |
| Category | Insulin Family |
References
- Encyclopeptide Database. “Insulin Therapy and Weight Gain” monograph. encyclopeptide.com.
Test Your Knowledge
Reinforce what you learned about Insulin Therapy and Weight Gain with interactive quizzes on Wikipept.
Take a Quiz on Wikipept